XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer

NCT00215722 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Carcinoma

Interventions

DRUG: Cetuximab

Sponsor

Grupo de Investigacao do Cancro Digestivo